Elezanumab, a clinical stage human monoclonal antibody that selectively targets repulsive guidance molecule A to promote neuroregeneration and neuroprotection in neuronal injury and demyelination models
Titel:
Elezanumab, a clinical stage human monoclonal antibody that selectively targets repulsive guidance molecule A to promote neuroregeneration and neuroprotection in neuronal injury and demyelination models
Auteur:
Huang, Lili Fung, Emma Bose, Sahana Popp, Andreas Böser, Preethne Memmott, John Kutskova, Yuliya A. Miller, Renee Tarcsa, Edit Klein, Corinna Veldman, Geertruida M. Mueller, Bernhard K. Cui, Yi-Fang